Fatty acids and lipid mediators

Prostaglandin E2 ethanolamide

Lipidomics · Prostanoid Mediator · Salivary Analysis

Prostaglandin E2 ethanolamide (PGE2-EA, prostamide E2) is a hybrid prostanoid-endocannabinoid lipid mediator formed at the intersection of the COX-2 and endocannabinoid pathways, contributing to both inflammatory pain sensitisation and nociceptive modulation. Its presence in saliva reflects active cyclooxygenase-mediated lipid inflammatory signalling and is relevant to monitoring NSAID and analgesic medication effects on the endocannabinoid system. Elevated levels indicate unresolved inflammatory pain states.

References

The studies behind this marker.

Handb Exp PharmacolThe role of the endocannabinoid system in painWoodhams SG et al. · ReviewPubMed ↗︎2015
Get in touch

Let’s build your panel together.

Contact us ↗︎